Hemato-Oncology: Understanding Blood Cancers & Bone Marrow Disorders
Blood cancers behave very differently from solid tumors. They involve the bone marrow, blood cells, and immune system, and often affect the entire body rather than one single organ. Disease-specific guides: leukemia, lymphoma, and multiple myeloma. For advanced treatment, bone marrow transplant or CAR-T cell therapy may be options to explore.
This page explains the biology, warning signs, and mechanisms behind blood cancers in a simple, clear way. Click a topic below to expand. Need to discuss your case? KIMS Hospitals or KIMS Sunshine to discuss your treatment options.
Watch: Bone Marrow Aspiration & Biopsy (Step-by-Step)
A bone marrow aspiration and biopsy is a common procedure used to diagnose blood cancers and other bone marrow disorders. In this video, I explain exactly why we do it, how it's done, what you'll feel, how long it takes, and how to care for the site afterward.
Most patients tolerate it well, and the procedure usually takes only a short time.
- Why this test is needed
- What happens during the procedure
- Aftercare + common questions
Explore by Topic
Blood diseases: first principles
How blood diseases behave differently
How blood diseases behave differently
What makes blood cancers unique?
Unlike solid tumors, blood cancers:
- Affect the bone marrow — where blood is made
- Circulate throughout the body
- Can change blood counts dramatically
- Often require close monitoring and repeated tests
Because the disease lives in the bloodstream and marrow, symptoms can appear in many different ways — fatigue, infections, bone pain, or falling counts.
How blood cancers can hide (sanctuary sites)
How blood cancers can hide (sanctuary sites)
Why some cancers return even after treatment. Some blood cancers can hide in areas where treatment drugs don't easily reach — sometimes called "sanctuary sites," such as: brain and spinal fluid (CNS), testes, and deep marrow spaces.
Even when blood reports look normal, tiny amounts of disease may remain hidden. This is one reason treatments are planned in phases and follow-up is essential.
Microscopic residual disease (MRD)
Microscopic residual disease (MRD)
When tests look normal but disease may still exist. Modern tests can detect extremely small numbers of cancer cells that regular tests cannot see. This is called Minimal / Microscopic Residual Disease (MRD).
It explains why treatment continues even after remission, why doctors monitor patients closely for years, and why relapse can happen even after good responses. MRD is one of the most important concepts in blood cancer care today.
Counts, transfusions and "why isn't it improving?"
Why counts keep dropping despite transfusions
Why counts keep dropping despite transfusions
Many patients expect blood transfusions to “fix the numbers.” But transfusions are temporary support — not a cure.
Think of your blood like a supermarket’s apple supply: fresh apples keep coming in, customers keep taking them away, and a transfusion is like restocking the shelf. But if the farm isn’t sending enough apples, or customers are taking them too fast, the shelf will empty again.
There are 3 main reasons counts keep dropping:
- The marrow is not producing enough cells
- Cells are being destroyed too quickly
- Blood is being lost somewhere in the body
Unless we treat the underlying cause, transfusions will only give temporary improvement. This is why doctors focus on diagnosing the reason behind low counts — not just repeatedly correcting numbers.
Red flags and symptom-led education
Low Back Pain and Multiple Myeloma: When Should You Worry?
Low Back Pain and Multiple Myeloma: When Should You Worry?
Persistent low back pain is one of the most common complaints in people over 50. In most cases, it is related to age, posture, or degenerative spine disease. But in some patients, it can be the earliest sign of a blood cancer called Multiple Myeloma. Unfortunately, this disease is often diagnosed late — sometimes nearly a year after symptoms begin — because the warning signs are mistaken for normal ageing or routine back problems. Recognizing the red flags early can prevent serious complications.
Red flags include: back pain that doesn’t improve with medication, pain that worsens at night, unexplained fatigue, and frequent infections.
In myeloma, the cancer weakens bones by creating “holes” called lytic lesions, making fractures more likely. It can also affect kidney function due to abnormal proteins and high calcium levels. Persistent pain plus fatigue should never be ignored. Early detection can prevent serious complications.
Frequently Asked Questions
How do blood cancers behave differently from solid tumours?
Blood cancers affect the bone marrow, blood cells, and immune system. They often involve the whole body rather than a single organ, and so behave differently from solid tumours in their symptoms, spread, and treatment — relying more on systemic therapy, transplant, and cellular therapies.
What is measurable (minimal) residual disease — MRD?
MRD refers to the very small amounts of cancer that can remain after treatment, below what a microscope can see. Specialised tests detect it and help guide further treatment and predict relapse risk. Read the full MRD explainer →
Why do blood counts keep dropping despite transfusions?
When the bone marrow is diseased, it may not produce enough healthy blood cells. Transfusions provide temporary support, but counts can fall again until the underlying disease is brought under control. Treating the cause is what ultimately stabilises the counts.
When should low back pain make me worry about myeloma?
Persistent, unexplained low back or bone pain — especially if it worsens at rest or at night — warrants evaluation, as multiple myeloma can involve the bones. Most back pain is not cancer, but unexplained persistent bone pain should be checked.
About Dr. Madhav Danthala
Dr. Madhav Danthala is a hemato-oncologist and bone marrow transplant physician at KIMS-Sunshine Hospitals, Begumpet, Hyderabad. He holds a DM in Medical Oncology from NIMS and completed fellowship training in leukemia and bone marrow transplant at Vancouver General Hospital, Canada. He has performed 300+ stem cell transplants and focuses on leukemia, lymphoma, myeloma, transplant, and second opinions.